Company Monitoring Page for Regeneron

latest headlines for company on cafepharma

German court blocks sale of Sanofi, Regeneron cholesterol drug
Biopharma Dive
Thu, 07/11/19 - 05:25 pm
Tags:
patents, Amgen, Sanofi, Regeneron, Germany, Praluent, Repatha
Sanofi and Regeneron's Dupixent scores 3rd FDA approval in sinusitis with nasal polyps
Fierce Pharma
Wed, 06/26/19 - 05:21 pm
Tags:
Sanofi, Regeneron, Dupixent, rhinosinusitis, nasal polyps, FDA
FDA Action Alert: Regeneron, Sanofi, Celgene
BioSpace
Mon, 06/24/19 - 07:27 pm
Tags:
FDA, drug approvals, Acer Therapeutics, Edsivo, Regeneron, Sanofi, Dupixent, Celgene, Revlimid, Alexion, Soliris, Dova Pharmaceuticals, Doptelet, Nabriva Therapeutics, Contepo, Retrophin, Thiola
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Readouts And IPOs
Yahoo/Benzinga
Sun, 06/23/19 - 02:04 pm
Tags:
Merck, Keytruda, Melinta Therapeutics, Amag Pharmaceuticals, Palatin, Acer Therapeutics, Sanofi, Regeneron, Alexion, Pfizer, Roche, Navidea Biopharmaceuticals, Ascendis Pharma, Scholar Rock, Adaptive Biotechnologies, BridgeBio, IPOs, G Medical Innovations, Karuna, Morphic Therapeutics
Rivals’ disappointing results in asthma trial drag down shares of Anaptys Bio
Stat
Fri, 06/21/19 - 10:00 am
Tags:
Sanofi, Regeneron, IL-33, asthma, monoclonal antibodies, REGN3500, AnaptysBio, Dupixent
Will The Introduction Of A Third Potent Cholesterol Lowering Drug Expand or Shrink The Market?
Forbes
Mon, 06/10/19 - 10:31 am
Tags:
The Medicines Company, Amgen, Sanofi, Regeneron, inclisiran, PCSK9 inhibitors
The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trial Readouts
Yahoo/Benzinga
Sun, 06/9/19 - 01:36 pm
Tags:
ADA, Merck, Keytruda, NGM Biopharmaceuticals, NGM313/MK-3655, Corbus Pharmaceuticals, Nektar, Galapagos, Kezar Life Sciences, Kura Oncology, Bluebird Bio, BeiGene, Global Blood Therapeutics, Blueprint Medicines, Regeneron, Arqule, Sunesis, Sutro BioPharma, Incyte, Geron, Forty Seven
ASCO Soundbites, vol. 3: Real-time approvals, Pfizer's second rodeo and 'the busiest ASCO ever'
Fierce Pharma
Tue, 06/4/19 - 12:18 pm
Tags:
ASCO 2019, Merck, Keytruda, FDA, Pfizer, AstraZeneca, Regeneron, Libtayo, Venclexta, Gazyva
Mark Your Calendar For These June PDUFA Dates
Yahoo/Benzinga
Sat, 06/1/19 - 12:52 pm
Tags:
FDA, Merck, Zerbaxa, XERIS, Gvoke HypoPen, Keytruda, Amag Pharmaceuticals, Palatin, Vyleesi, Acer Therapeutics, Edsivo, Sanofi, Regeneron, Dupixent, Alexion, Soliris, Retrophin, Thiola, Allergan, Botox
Go or no go? Merck, Regeneron and Alexion await US expansion
EP Vantage
Thu, 05/30/19 - 09:39 am
Tags:
Merck, Keytruda, Sanofi, Regeneron, Dupixent, Alexion, Soliris, FDA, Dova Pharmaceuticals, Retrophin
FDA approves Regeneron’s Eylea for diabetic retinopathy
Pharmaforum
Tue, 05/14/19 - 09:58 am
Tags:
Regeneron, Eylea, diabetic retinopathy, FDA, Bayer
Regeneron’s star bispecific is linked to 2 deaths in a small study — which was no help for its Q1 call
Endpoints
Wed, 05/8/19 - 09:41 am
Tags:
Regeneron, REGN1979, bispecific antibodies
Regeneron bags Calixar tech to support antibody discovery effort
Fierce Biotech
Mon, 04/29/19 - 09:44 pm
Tags:
Regeneron, Calixar, antibodies, antibody discovery
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Readouts And IPOs
Yahoo/Benzinga
Sun, 04/28/19 - 10:00 pm
Tags:
Regeneron, Sanofi, Praluent, FDA, Heron Therapeutics, HTX-011, Nabiva, Orchard Therapeutics, Akari Therapeutics, Aldeyra Therapeutics, BioTime, Audentes Therapeutics, Adaptimmune, GW Pharma, Ionis, Biogen, Ovid Therapeutics, TransMedics, IPOs, Trevi Therapeutics
Praluent's lower list price isn't yielding better sales yet
Biopharma Dive
Sun, 04/28/19 - 12:36 pm
Tags:
Sanofi, Regeneron, Praluent, drug pricing
U.S. FDA approves expanded label for Regeneron/Sanofi's cholesterol drug
Yahoo/Reuters
Sat, 04/27/19 - 10:20 am
Tags:
Regeneron, Sanofi, Praluent, MACE, FDA
Safety setback for Pfizer, Lilly pain drug should have Regeneron and Teva feeling nervous
Biopharma Dive
Mon, 04/22/19 - 03:37 pm
Tags:
Pfizer, Eli Lilly, painkillers, tanezumab, Regeneron, Teva Pharmaceutical, fasinumab
Regeneron, Alnylam spell out a research alliance that could run beyond a decade, with billions built in for success
Endpoints
Thu, 04/11/19 - 10:11 am
Tags:
Regeneron, Alnylam, R&D
Alnylam Gets $800M From Regeneron to Bring RNAi to Eye, Brain Diseases
Xconomy
Mon, 04/8/19 - 09:56 am
Tags:
Alnylam, Regeneron, RNAi, eye health, brain diseases
FDA approves Dupixent for atopic dermatitis in adolescents
BioCentury
Mon, 03/11/19 - 10:15 pm
Tags:
Dupixent, Regeneron, Sanofi, FDA, atopic dermatitis

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.